Medical Condition News

RSS

Lindus Health secures funding to accelerate the use of technology for revolutionizing clinical trials

Ground-breaking trials run by London-based start-up Lindus Health are kicking off to find innovative treatments for conditions including tinnitus, insomnia and progressive childhood short-sightedness.

5 Jun 2023

Long-haul COVID-19: 1 in 5 still battle symptoms two years post-infection

Up to two years after infection, around 18% of unvaccinated individuals experience post-COVID-19 condition, highlighting higher symptom risk compared to controls. Effective interventions are crucial in mitigating the burden of this condition, and comprehensive clinical trial design considering multiple outcome measures, recovery rates, and symptom heterogeneity is essential for accurate interpretation.

5 Jun 2023

Research opens door to new, more efficient drug combinations for acute myeloid leukemia

Acute myeloid leukemia (AML) is a very aggressive disease in which cells proliferate abnormally, invading the bone marrow and interfering with normal blood cell production. It is the most common acute leukemia in adults with the worst prognosis.

5 Jun 2023

Unraveling the complexity of 'Long-COVID' and its impact on breathing

More than a third of COVID-19 patients experience long-lasting symptoms, known as post-COVID-19 condition or long COVID, with breathlessness being a commonly reported symptom. Pulmonary complications, such as fibrosis and thromboembolic disease, require careful assessment, and non-pharmacological interventions like pulmonary rehabilitation can help manage breathlessness.

5 Jun 2023

UVA discoveries highlight the different roles of blood vessels in solid tumors

Two new discoveries from the Dudley lab at UVA Cancer Center highlight the different roles of blood vessels in solid tumors – and the findings could help prevent breast cancer from spreading and enhance the effectiveness of one of the most important new cancer treatments in many years.

4 Jun 2023

Testing for dangerous 'zombie' cells could increase the number of donor hearts for transplant

Testing older potential organ donors for dangerous 'zombie' cells could help to increase the number of hearts available for transplant, according to research part-funded by the British Heart Foundation (BHF) and presented at the British Cardiovascular Society conference in Manchester.

4 Jun 2023

Serious heart attacks more likely to happen on a Monday

Serious heart attacks are more likely to happen at the start of the working week than at any other time, according to new research presented today at the British Cardiovascular Society conference in Manchester.

4 Jun 2023

Study suggests possible new treatment option for people with slow-growing but deadly brain tumor

In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening.

4 Jun 2023

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly lower risk of their cancer getting worse than patients treated with brentuximab vedotin, a monoclonal antibody, and AVD (BV-AVD) a year after starting treatment.

4 Jun 2023

Stopping treatment at two years does not seem to compromise overall survival in patients with advanced lung cancer

Over the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment for patients with advanced lung cancer, helping many live longer lives and improving overall survival for the disease.

4 Jun 2023

Can exercise ease anxiety? Study investigates the potentials and pitfalls of fitness as therapy

A comprehensive analysis of 25 clinical trials on exercise interventions reveals inconclusive and negative results regarding its efficacy in treating anxiety disorders. Methodological limitations indicate exercise is not currently an effective intervention for anxiety.

4 Jun 2023

Mediterranean diet in pregnancy: A recipe for reduced stress and improved sleep

A Mediterranean diet intervention during pregnancy reduces maternal stress and anxiety levels, improves sleep quality, and increases the cortisone/cortisol ratio. These findings highlight the positive impact of dietary changes on maternal well-being during gestation.

4 Jun 2023

Study offers the most comprehensive archive of cellular, molecular features involved in psoriatic disease

Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by the activity of key cells and signaling pathways, a new study shows.

2 Jun 2023

Researchers characterize a unique molecular mechanism of early stages of programmed cell death

Researchers have for the first time characterized a unique molecular mechanism of the early stages of programmed cell death or apoptosis, a process which plays a crucial role in prevention of cancer.

2 Jun 2023

American College of Cardiology to host annual Care of the Athletic Heart course

The American College of Cardiology will host the annual Care of the Athletic Heart course on June 8-10, 2023, in Washington, including poster abstracts and educational sessions.

2 Jun 2023

ACNAP 2023 highlights the artistic and scientific dimensions of cardiovascular care

Hear from patients, nurses and allied health professionals about hot topics in cardiovascular disease at ACNAP 2023, a scientific congress of the European Society of Cardiology.

2 Jun 2023

Study finds substantial differences in cancer drug funding decisions across high-income countries

Despite the use of similar assessment criteria when deciding whether new cancer drugs should receive funding, there are substantial differences in drug funding decisions, across comparable high-income countries.

2 Jun 2023

Study of immunotherapy for brain cancer metastases shows promising results

In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving longer than two years.

2 Jun 2023

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis.

2 Jun 2023

Exposure to Agent Orange associated with increased risk of myeloproliferative neoplasms in veterans

Research conducted at Georgetown University's Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins.

2 Jun 2023

Medical Condition News

Lindus Health secures funding to accelerate the use of technology for revolutionizing clinical trials

Long-haul COVID-19: 1 in 5 still battle symptoms two years post-infection

Research opens door to new, more efficient drug combinations for acute myeloid leukemia

Unraveling the complexity of 'Long-COVID' and its impact on breathing

UVA discoveries highlight the different roles of blood vessels in solid tumors

Testing for dangerous 'zombie' cells could increase the number of donor hearts for transplant

Serious heart attacks more likely to happen on a Monday

Study suggests possible new treatment option for people with slow-growing but deadly brain tumor

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

Stopping treatment at two years does not seem to compromise overall survival in patients with advanced lung cancer

Can exercise ease anxiety? Study investigates the potentials and pitfalls of fitness as therapy

Mediterranean diet in pregnancy: A recipe for reduced stress and improved sleep

Study offers the most comprehensive archive of cellular, molecular features involved in psoriatic disease

Researchers characterize a unique molecular mechanism of early stages of programmed cell death

American College of Cardiology to host annual Care of the Athletic Heart course

ACNAP 2023 highlights the artistic and scientific dimensions of cardiovascular care

Study finds substantial differences in cancer drug funding decisions across high-income countries

Study of immunotherapy for brain cancer metastases shows promising results

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Exposure to Agent Orange associated with increased risk of myeloproliferative neoplasms in veterans

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News